NYSE · XPEV
XPeng financials
$9.47−4.82%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q4 '25 Dec 31 | Q4 '24 Dec 31 | Q4 '23 Dec 31 | Q4 '22 Dec 31 | Q4 '21 Dec 31 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Gross margin | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| Net income | — | — | — | — | — |
| Net margin | — | — | — | — | — |
| Diluted EPS | — | — | — | — | — |
| EBITDA | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating cash flow | — | — | — | — | — |
| Free cash flow | — | — | — | — | — |
| Diluted shares | 1,904.0M | 1,891.4M | 1,740.9M | 1,712.5M | 1,642.9M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|
| Cash & equivalents | $2.48B | $2.55B | $2.98B | $2.12B |
| Short-term investments | $459.9M | $102.9M | $110.4M | $2.41B |
| Total debt | $4.67B | $2.86B | $1.66B | $1.26B |
| Total assets | $14.75B | $11.33B | $11.89B | $10.36B |
| Total liabilities | $10.40B | $7.05B | $6.76B | $5.01B |
| Shareholders' equity | $4.34B | $4.28B | $5.13B | $5.35B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology